February 2022

Hy-genie, a portfolio company within the Deepbridge Life Sciences EIS fund, was a worthy winner of Business Cloud's MedTech 50 innovation ranking last year - with the help from Alder Hey Children's Hospital in its progress. 

SmallSpark Space Systems, the award-winning rocket propulsion innovation company, has announced the closure of a significant overfunding of its recent seed round, securing a commitment for an additional £1.1 million investment on top of the £500,000 scale-up investment raised last year. With additional Government research funding of £200,000 over the past 18 months, this brings the total capital the company has raised for its technologies to £2.2 million, led by Deepbridge Capital and government co-funding. 

Deepbridge Capital has been shortlisted for the Deal of the Year (Transaction size below £2.5 million) Award at the upcoming 2022 Insider Media, Northern Ireland Dealmakers Awards. 

The 2022 Northern Ireland Dealmakers Awards will be honouring the achievements of the highly committed professional corporate finance community, which has supported businesses across Northern Ireland over the last 12 months. 

IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently been featured on The Seven on BBC Scotland. This interview was filmed in the Glasgow Science Centre.

Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Professional Adviser to share his thoughts regarding the world of tax-efficient investments and assesses which relief is the trump card for advisers and clients.

As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund. 

The Deepbridge Innovation SEIS enables private investors to access a portfolio of early-stage companies within the UK's vibrant technology sector, whilst investors are able to benefit from the generous potential tax reliefs via the Government's Seed Enterprise Investment Scheme. 

Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Money Marketing to share his thoughts regarding how the Enterprise Investment Scheme (EIS) can help reduce client income tax bills. 

FluoretiQ, which is part of the Deepbridge Life Sciences EIS portfolio, as of February 21st 2022, has announced the completion of a £1.1 million, pre-series A investment. The funding round was led by Deepbridge Capital, with significant participation from MAINStream, OION, SAIC and existing investors. 

VoxSmart Ltd, which is part of the Deepbridge Technology Growth EIS portfolio, has recently been selected by public vote as the winner of the 'Best Trade Reconstruction Solution'  in the TradingTech Insight Awards Europe 2022 by the A-Team Group. 

These awards recognise outstanding performance by RegTech vendors developing data and technology solutions across the financial industry, and other regulated sectors.